Volume 86, Issue 2, Pages (August 2014)

Slides:



Advertisements
Similar presentations
Membrane Function Signal Transduction. I. Introduction to Receptors & Signal Transduction.
Advertisements

Volume 76, Issue 9, Pages (November 2009)
From Delivery to Dialysis: Does Preeclampsia Count?
Figure 1 Pre-eclampsia prevents VEGF signalling in endothelial cells
Endothelin-1: a key pathological factor in pre-eclampsia?
Eric Niederhoffer SIU-SOM
HFpEF, a Disease of the Vasculature: A Closer Look at the Other Half
Figure 1 The role of GPCRs in the regulation of human physiology
Frederic Rahbari-Oskoui, MD, MS  American Journal of Kidney Diseases 
Mitchell H. Rosner, W. Kline Bolton  Kidney International 
Renal Disorders in Pregnancy: Core Curriculum 2019
Volume 79, Issue 9, Pages (May 2011)
Volume 83, Issue 3, Pages (March 2013)
New Insights Into the Pathophysiology of Renovascular Hypertension
Management of advanced renal cancer
Biomarker explorations in acute kidney injury: the journey continues
FGF23 or PTH: which comes first in CKD ?
Vascular endothelial dysfunction in cirrhosis
Daniel A. Langer, Vijay H. Shah  Journal of Hepatology 
Role of Endothelin in the Pathogenesis of Hypertension
Preeclampsia: A renal perspective
The kallikrein–kinin system in health and in diseases of the kidney
The kallikrein–kinin system in diabetic nephropathy
John P. Middleton, Patrick H. Pun  Kidney International 
Peter Celec, Yoshikazu Yonemitsu  Pathophysiology 
Volume 85, Issue 3, Pages (March 2014)
Vascular Endothelial Growth Factor (VEGF) Pathway
Volume 76, Issue 9, Pages (November 2009)
Yasuko Iwakiri, Vijay Shah, Don C. Rockey  Journal of Hepatology 
Mark S Taylor, A.Marie McMahon, Jason D Gardner, Joseph N Benoit 
Steven G. Coca, Swathi Singanamala, Chirag R. Parikh 
C.Y. Hsu, J.D. Ordoñez, G.M. Chertow, D. Fan, C.E. McCulloch, A.S. Go 
The sources of oxidative stress in the vessel wall
Comorbidity and confounding in end-stage renal disease
Lipid redistribution in renal dysfunction
Let's look at cysts from both sides now
Volume 70, Issue 11, Pages (December 2006)
Volume 76, Issue 11, Pages (December 2009)
Reducing lipids for CV protection in CKD patients—current evidence
The biology of preeclampsia
Margus Annuk, Mihkel Zilmer, Bengt Fellström
Volume 70, Issue 10, Pages (November 2006)
Volume 85, Issue 2, Pages (January 2014)
Karsten Bartels, Almut Grenz, Holger K. Eltzschig  Kidney International 
Ferruh Artunc, Friedhelm Hildebrandt, Kerstin Amann 
Volume 69, Issue 12, Pages (June 2006)
Volume 73, Issue 12, Pages (June 2008)
Macrophages and hypoxia in human chronic kidney disease
David M. Charytan, John P. Forman  Kidney International 
Calcium sensing in podocytes
Thomas Mueller, Benjamin Dieplinger  Kidney International 
Volume 81, Issue 8, Pages (April 2012)
Atrial fibrillation in end-stage renal disease: an emerging problem
Matrix metalloproteinases and matrix receptors in progression and reversal of kidney disease: therapeutic perspectives  Pierre Ronco, Christos Chatziantoniou 
Ho Jae Han, Soo Hyun Park, Hyun Ju Koh, Mary Taub  Kidney International 
Volume 81, Issue 8, Pages (April 2012)
New paradigms in cell death in human diabetic nephropathy
Karen A. Griffin, Anil K. Bidani  Kidney International 
Volume 64, Issue 2, Pages (August 2003)
Immunity unmasks APOL1 in collapsing glomerulopathy
The emerging role of phosphate in vascular calcification
Hemodialysis and L-arginine, but not D-arginine, correct renal failure-associated endothelial dysfunction  Malcolm F. Hand, William G. Haynes, David J.
Immunoregulatory role of TNFα in inflammatory kidney diseases
David A. Ferenbach, David C. Kluth, Jeremy Hughes  Kidney International 
The complex field of interplay between vasoactive agents
Regulation of renal function by prostaglandin E receptors
Volume 75, Issue 7, Pages (April 2009)
Biology of endothelin receptors in the collecting duct
Josée Bouchard, Ravindra L. Mehta  American Journal of Kidney Diseases 
Proteinuria and hypertension with tyrosine kinase inhibitors
Presentation transcript:

Volume 86, Issue 2, Pages 275-285 (August 2014) Advances in the pathophysiology of pre-eclampsia and related podocyte injury  Iasmina M. Craici, Steven J. Wagner, Tracey L. Weissgerber, Joseph P. Grande, Vesna D. Garovic  Kidney International  Volume 86, Issue 2, Pages 275-285 (August 2014) DOI: 10.1038/ki.2014.17 Copyright © 2014 International Society of Nephrology Terms and Conditions

Figure 1 Etiologies and pathophysiology of pre-eclampsia. Several different signaling pathways may have a role, ultimately converging at the point of systemic endothelial dysfunction, hypertension, and proteinuria. AT1-AA, autoantibodies to the angiotensin II type 1 receptor; AT1-B2 heterodimers, angiotensin II type 1 receptor-bradykinin type 2 receptor heterodimers; CO, carbon monoxide; CKD, chronic renal disease; CTD, connective tissue disease; DM, diabetes mellitus; HELLP, hemolysis, elevated liver enzymes, low platelet count; IL-6, interleukin 6; LFT, liver function tests; PlGF, placental growth factor; PRES, posterior reversible encephalopathy syndrome; sFlt-1, soluble fms-like tyrosine kinase 1; TNFα, tumor necrosis factor α; VEGF, vascular endothelial growth factor. *Reduced risk for pre-eclampsia. Kidney International 2014 86, 275-285DOI: (10.1038/ki.2014.17) Copyright © 2014 International Society of Nephrology Terms and Conditions

Figure 2 Regulation of nitric oxide (NO) synthesis. Left side: calcium-dependent, mediated by acetylcholine and bradykinin. Right side: calcium-independent, stimulated by vascular endothelial growth factor (VEGF). In pre-eclampsia, elevated levels of soluble fms-like tyrosine kinase 1 (sFlt-1) may act as a nonsignaling decoy, thus interfering with VEGF-dependent phosphorylation/stimulation of endothelial NOS (eNOS). Akt, protein kinase B; Arg, arginine; cGMP, cyclic guanosine monophosphate; DAG, diacylglycerol; ER, endoplasmic reticulum; Gq-P, phosphorylated Gq protein; IP3, inositol triphosphate; PIP2, phosphatidylinositol biphosphate; PLC, phospholipase C. Kidney International 2014 86, 275-285DOI: (10.1038/ki.2014.17) Copyright © 2014 International Society of Nephrology Terms and Conditions

Figure 3 Possible mechanisms of the association between pre-eclampsia and future renal disease. CKD, chronic kidney disease; ESRD, end-stage renal disease. Kidney International 2014 86, 275-285DOI: (10.1038/ki.2014.17) Copyright © 2014 International Society of Nephrology Terms and Conditions